Healthy adults
Conditions
Interventions
Take 2 tablets of test foods daily for 12 weeks.
Take 2 tablets of placebo foods daily for 12 weeks.
Sponsors
IMEQRD Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 20 to under 65 at the time of informed consent. 2. Male and Female 3. Those who suffered from upper respiratory tract infection during the winter season within the last two years 4. Those who can obtain written consent
Exclusion criteria
Exclusion criteria: 1.Those who are currently under continuous treatment with drugs. 2. Those who have a positive reaction in the infectious disease test. 3. Those who are on a diet or exercise therapy under the supervision of a doctor. 4. Those who have a current or history of serious illness. 5. Those with atopic dermatitis, bronchial asthma, or chronic bronchitis 6. Those who have hay fever and allergic rhinitis (including seasonal and perennial) 7. Those who are currently using quasi-drugs, foods for specified health uses, health foods and supplements. Those who can quit during the test period after obtaining consent are allowed to participate. 8. Those who have been vaccinated against influenza vaccine after October 2020, or who are planning to be vaccinated during the test period 9. Those who have a past and current medical history of drug or food allergy. 10. Those who consume alcohol excessively (alcohol equivalent 60g or more / day) 11. Those who have excessive smoking habits (21 or more cigarettes / day) 12. Those who work in shifts, such as those who work night shifts 13. Those who are planning to travel abroad during the test period 14. Those who wish to become pregnant, breastfeeding, or during the test period 15. Those who have participated in other clinical trials within one month before obtaining consent, or those who plan to participate during the trial period 16. Those who are judged by the investigator or coordinator to be unsuitable for participating in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Questionnaires to assess health condition | — |
Secondary
| Measure | Time frame |
|---|---|
| Indicators for upper respiratory tract infection, biomarkers | — |
Countries
Japan
Contacts
Public ContactHirokuni Kayama
IMEQRD Co., Ltd Planning and Sales Department
Outcome results
None listed